Performance
Trailing returns
| 1 day |
| -0.52% | |||
| 1 week |
| -0.17% | |||
| 4 week | +3.95% |
| |||
| 3 month | +7.03% |
| |||
| YTD | +12.82% |
| |||
| 1 year | +24.67% |
| |||
| 3 years* | +14.41% |
| |||
| 5 years* | +5.59% |
| |||
| *annualised | |||||
| Best 3-month return | +19.44% | |
| Worst 3-month return | -22.79% |
Morningstar statistics
Morningstar category: World Stock
| Return | Risk | Rating | |
| 3 years | Above Average | Low |
 
|
| 5 years | High | Low |
|
| 10 years | - | - | - |
| Overall | Above Average | Low |
|
Morningstar style Learn more
| Large | |||
| Mid | |||
| Small | |||
| Value | Blend | Growth |
Key statistics
| Total assets | 1,571.41M | |
| Front load | - | |
| Deferred load | - | |
| Expense ratio | 0.87% | |
| Management fee | - | |
| Fund family | BlackRock |
Asset allocation
| Cash | 3.86% | |
| Stocks | 96.14% | |
| Bonds | 0.00% | |
| Other | 0.00% |
Purchase information
| Initial | $2,000,000 |
11.530.00(0.00%)
May 24, 4:00pm GMT-4
Overall Morningstar RatingTM
Description
The investment seeks to provide a level of current income that exceeds the average yield on global stocks generally; it seeks to provide long-term capital appreciation. The fund invests at least 80% of net assets in dividend-paying equity securities and at least 40% of its assets outside of the U.S. It may invest in securities of non-U.S. issuers that can be U.S. dollar based or non-U.S. dollar based. The fund may invest in securities of companies of any market capitalization, but intends to invest primarily in securities of large capitalization companies. It may invest up to 20% of total assets in global fixed income securities. The fund is non-diversified.
Fund filings (PDF) »
Fund filings (PDF) »
Asset managers:
James Bristow (Started: Jan 1, 2013)
Stuart Reeve (Started: Nov 1, 2010)
Andrew Wheatley-Hubbard (Started: Jul 13, 2012)
James Bristow (Started: Jan 1, 2013)
Stuart Reeve (Started: Nov 1, 2010)
Andrew Wheatley-Hubbard (Started: Jul 13, 2012)
Risk
| 1 year | 3 years | 5 years | 10 years | ||
| Alpha* | 5.15 | 6.75 | 5.45 | - | |
| Beta* | 0.57 | 0.54 | 0.58 | - | |
| Mean annual return | 1.35 | 0.98 | 0.55 | - | |
| R-squared* | 81.14 | 79.76 | 84.60 | - | |
| Standard deviation | 10.33 | 11.86 | 14.51 | - | |
| Sharpe ratio | 1.56 | 0.98 | 0.44 | - | |
| * Against standard index | |||||
Top 10 holdings
| Security | Net Assets | |
| Roche Holding AG (RHHVF) | 3.15% | |
| Pfizer Inc (PFE) | 3.08% | |
| Sanofi (SAN) | 3.08% | |
| Imperial Tobacco Group PLC (IMT) | 2.87% | |
| Novartis AG (NVSEF) | 2.80% | |
| Microsoft Corporation (MSFT) | 2.77% | |
| Coca-Cola Co (KO) | 2.67% | |
| Merck & Co Inc (MRK) | 2.60% | |
| GlaxoSmithKline PLC (GLAXF) | 2.50% | |
| Royal Dutch Shell PLC Class B (RDSB) | 2.37% |